These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10884441)

  • 1. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.
    Kimura M; Robinson RG; Kosier JT
    Stroke; 2000 Jul; 31(7):1482-6. PubMed ID: 10884441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
    Kimura M; Tateno A; Robinson RG
    Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
    Narushima K; Chan KL; Kosier JT; Robinson RG
    Am J Psychiatry; 2003 Jun; 160(6):1157-62. PubMed ID: 12777275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
    Chan KL; Campayo A; Moser DJ; Arndt S; Robinson RG
    Arch Phys Med Rehabil; 2006 Jun; 87(6):793-8. PubMed ID: 16731214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.
    Chemerinski E; Robinson RG; Arndt S; Kosier JT
    J Nerv Ment Dis; 2001 Jul; 189(7):421-5. PubMed ID: 11504318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cognitive impairment cause post-stroke depression?
    Murata Y; Kimura M; Robinson RG
    Am J Geriatr Psychiatry; 2000; 8(4):310-7. PubMed ID: 11069271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine.
    Nebes RD; Pollock BG; Houck PR; Butters MA; Mulsant BH; Zmuda MD; Reynolds CF
    J Psychiatr Res; 2003; 37(2):99-108. PubMed ID: 12842163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
    Cha DS; Best MW; Bowie CR; Gallaugher LA; Woldeyohannes HO; Soczynska JK; Lewis G; MacQueen G; Sahakian BJ; Kennedy SH; Lui JP; Mansur RB; McIntyre RS
    J Affect Disord; 2017 Mar; 210():57-65. PubMed ID: 28013123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind randomized treatment of poststroke depression using nefiracetam.
    Robinson RG; Jorge RE; Clarence-Smith K
    J Neuropsychiatry Clin Neurosci; 2008; 20(2):178-84. PubMed ID: 18451188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.
    Dobkin RD; Menza M; Bienfait KL; Gara M; Marin H; Mark MH; Dicke A; Tröster A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):188-95. PubMed ID: 20463113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
    Keers R; Uher R; Gupta B; Rietschel M; Schulze TG; Hauser J; Skibinska M; Henigsberg N; Kalember P; Maier W; Zobel A; Mors O; Kristensen AS; Kozel D; Giovannini C; Mendlewicz J; Kumar S; McGuffin P; Farmer AE; Aitchison KJ
    J Affect Disord; 2010 Dec; 127(1-3):337-42. PubMed ID: 20609482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous mastoid electrical stimulator improves Poststroke depression and cognitive function in patients with Ischaemic stroke: a prospective, randomized, double-blind, and sham-controlled study.
    Lu T; He L; Zhang B; Wang J; Zhang L; Dong WW; Yang H
    BMC Neurol; 2020 May; 20(1):217. PubMed ID: 32471373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antidepressants on the course of disability following stroke.
    Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo.
    Green TD; Reynolds CF; Mulsant BH; Pollock BG; Miller MD; Houck PR; Mazumdar S; Dew MA; Kupfer DJ
    J Geriatr Psychiatry Neurol; 1999; 12(2):67-71. PubMed ID: 10483927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.